Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

XCUR

Exicure (XCUR)

Exicure Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:XCUR
일자시간출처헤드라인심볼기업
2024/05/1705:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XCURExicure Inc
2024/05/1705:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2024/05/1705:45Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:XCURExicure Inc
2024/05/1705:40Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:XCURExicure Inc
2024/05/1705:08Business WireExicure, Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:XCURExicure Inc
2024/05/1605:45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:XCURExicure Inc
2024/04/2305:01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-KNASDAQ:XCURExicure Inc
2024/03/0702:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2024/03/0508:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2024/03/0507:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XCURExicure Inc
2024/02/0606:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2024/02/0606:01Business WireExicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of HepatitisNASDAQ:XCURExicure Inc
2024/01/1706:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2023/12/0208:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2023/12/0206:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2023/11/2906:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2023/11/2906:01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-QNASDAQ:XCURExicure Inc
2023/11/1506:28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:XCURExicure Inc
2023/10/0706:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2023/09/3006:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2023/09/2806:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2023/09/1406:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2023/09/0102:33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2023/09/0102:33Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2023/09/0102:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2023/08/2322:48Business WireExicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of DirectorsNASDAQ:XCURExicure Inc
2023/08/2322:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
2023/08/1907:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
2023/08/1205:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XCURExicure Inc
2023/08/1205:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
 검색 관련기사 보기:NASDAQ:XCUR